Fusion Pharmaceuticals Inc. Long-Term Debt, Maturity, Year Five
Fusion Pharmaceuticals Inc. had Long-Term Debt, Maturity, Year Five of $6.09 million as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2023-03-16
- 2022-12-31: Long-Term Debt, Maturity, Year Five $6.09M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2022-12-31 | $6.09M 10-K · filed 2023-03-16 |